Latest / Public Health Review Morning Edition

500: Xylazine Plan, Diverse Executives Address Equity
Dr. Rahul Gupta, Director of National Drug Control Policy at the White House, outlines the federal government's response to the threat of Xylazine; the 2024 Diverse Executives Leading in Public Health (DELPH) Program is accepting applications for professional development; a new ASTHO blog article explains how data modernization intersects with diversity, equity, and inclusion; and the Morning Edition celebrates its 500th episode.
ASTHO Webpage: Public Health Officials Stand Ready to Implement White House Xylazine Response Plan
ASTHO Webpage: Diverse Executives Leading in Public Health…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.